Biodexa Pharmaceuticals (BDRX) Liabilities and Shareholders Equity (2013 - 2026)
Biodexa Pharmaceuticals' Liabilities and Shareholders Equity came in at $17.07 million for the quarter ended Jun 30, 2026, down 13.7% from $19.78 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals' Liabilities and Shareholders Equity was $23.97 million, up 26.9% from the prior year.
- Liabilities and Shareholders Equity has increased in each of the last three years, with a five-year compound annual growth rate of 13.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Liabilities and Shareholders Equity was $18.89 million in the year ended Dec 31, 2024 (+44.1%), $13.11 million in the year ended Dec 31, 2023 (+91.8%), $6.84 million in the year ended Dec 31, 2022 (-61.5%) and $17.77 million in the year ended Dec 31, 2021 (+40.9%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Liabilities and Shareholders Equity since the quarter ended Dec 31, 2023.
- Year-over-year, Liabilities and Shareholders Equity increased in three of the last four quarters, with growth averaging 17.7%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in the quarter ended Dec 31, 2023 (growth of 101.9%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 62.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - | 17.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.07 Mn |
| Dec 31, 2025 | 24.18 Mn |
| Jun 30, 2025 | 19.78 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Jun 30, 2024 | 17.63 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Jun 30, 2022 | 12.19 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Jun 30, 2021 | 11.57 Mn |
| Dec 31, 2020 | 12.96 Mn |
| Jun 30, 2020 | 14.90 Mn |
| Dec 31, 2019 | 39.72 Mn |
| Jun 30, 2019 | 36.70 Mn |
| Dec 31, 2018 | 26.31 Mn |
| Jun 30, 2018 | 48.84 Mn |
| Dec 31, 2017 | 65.35 Mn |
| Jun 30, 2017 | 57.86 Mn |
| Dec 31, 2016 | 70.48 Mn |
API Access
Biodexa Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();